|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Sales Team Leader
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) ÀçÇÐ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
7³â¡è |
ä¿ë½Ã |
12.04 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] QC Project management
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) ÀçÇÐ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
5³â¡è |
ä¿ë½Ã |
09.09 |
|
|
¿¡À̽ºÆÄÆ®³Ê½º |
¿Ü±¹°è ÀǾà Àü¹® ¸¶ÄÉÆà ¸®¼Ä¡ ȸ»ç ÆÀÀå±Þ ¸ðÁý
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) ÀçÇÐ |
CRA/ÀÓ»óPM/CRM |
5³â¡è |
ä¿ë½Ã |
04.30 |
|
|
(ÁÖ)¾¾¾ØÆÊ |
¿¬±¸¼Ò Ã¥ÀÓ¿¬±¸¿ø ¹× ¿¬±¸¿ø ¸ðÁý
¼¿ï ¼´ë¹®±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
¿¬±¸/¿¬±¸±âȹ |
5³â¡è |
ä¿ë½Ã |
05.20 |
|
|
(ÁÖ)¸ÞµåÆÄÅ© |
(ÁÖ)¸ÞµåÆÄÅ© [¼¿ï] Àλç / Ãѹ« °æ·Â ä¿ë
¼¿ï ¿µµîÆ÷±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
Àλç/ÀÎÀç°³¹ß/ä¿ë/±³À° |
5³â¡è |
ä¿ë½Ã |
02.23 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] QC Project management
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) ÀçÇÐ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
5³â¡è |
ä¿ë½Ã |
09.19 |
|
|
JC Econet |
ÇؿܸÞÀÌÀúÁ¦¾àȸ»ç Health Science Associate
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) ÀçÇÐ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
5³â¡è |
ä¿ë½Ã |
05.24 |
|
|
ÆĶó°ïÄÁ¼³Æà |
¿Ü±¹°è Á¦¾àȸ»ç Regional CRM(¾Æ½Ã¾Æ Áö¿ª ÀÓ»ó´ã´ç ¸Å´ÏÀú
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) ÀçÇÐ |
CRA/ÀÓ»óPM/CRM |
5³â¡è |
ä¿ë½Ã |
05.31 |
|
|
ÁÖ½Äȸ»ç ¿À»óÇコÄɾî |
»ç¾÷±âȹ ºÐ¾ß °æ·ÂÁ÷ ä¿ë
°æ±â ¾È¾ç½Ã µ¿¾È±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
5³â¡è |
ä¿ë½Ã |
09.13 |
|
|
ÁÖ½Äȸ»ç ¿À»óÇコÄɾî |
QA ºÐ¾ß °æ·ÂÁ÷ ä¿ë
°æ±â ¾È¾ç½Ã µ¿¾È±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
ÀÓ»ó BD/RA/QA |
4³â¡è |
ä¿ë½Ã |
09.13 |
|
|
ÆÄ·º¼¿ ÄÚ¸®¾Æ |
ÆĶô¼¿ ÄÚ¸®¾Æ -Clinical Lead (CPS Department)
¼¿ï °³²±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
CRA/ÀÓ»óPM/CRM |
4³â¡è |
ä¿ë½Ã |
08.08 |
|
|
OOȍ |
±¹³» Áß°ß Á¦¾à»ç Á¦Á¦¿¬±¸¼Ò °æ·ÂÁ÷ ¸ðÁý
¼¿ï ±¸·Î±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
¿¬±¸/¿¬±¸±âȹ |
3³â¡è |
ä¿ë½Ã |
06.14 |
|
|
DKSH Korea Ltd. |
Rx/Pharma Marketing Specialist (Àü¹®ÀǾàÇ° ¸¶ÄÉÆÃ)
¼¿ï °³²±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
3³â¡è |
ä¿ë½Ã |
06.13 |
|
|
(ÁÖ)¸ß¾ÆÀ̾¾¿¡½º |
¸¶ÄÉÆà ´ã´çÀÚ Ã¤¿ë
¼¿ï ¸¶Æ÷±¸, ¼¿ï ¸¶Æ÷±¸ | ´ëÇÐ(4³â) ÀçÇÐ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
3³â¡è |
ä¿ë½Ã |
11.22 |
|
|
¿¡À̽ºÆÄÆ®³Ê½º |
¿Ü±¹°è ¸¶ÄÉÆÃȸ»ç Outcomes research team
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) ÀçÇÐ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
3³â¡è |
ä¿ë½Ã |
02.18 |
|